Inventor · disambiguated record
Morita Iwami
Also filed as: IWAMI MORITA
24 granted patents·1 pending application·96 citations·filing 1983–2021
94Inventor score
Top patents by PatentIndex Score
25 records- 0184US10106509B2Method for producing kakeromycin and derivatives thereofOP BIO FACTORY CO LTD·Filed 2016·Granted Oct 23, 2018·2 cites·9 claims
- 0282US11066374B2Method for producing kakeromycin and derivatives thereofOP BIO FACTORY CO LTD·Filed 2018·Granted Jul 20, 2021·1 cites·10 claims
- 0382US10618876B2Method for producing kakeromycin and derivatives thereofOP BIO FACTORY CO LTD·Filed 2018·Granted Apr 14, 2020·1 cites·16 claims
- 0481US10703732B2Method for producing kakeromycin and derivatives thereofOP BIO FACTORY CO LTD·Filed 2018·Granted Jul 7, 2020·1 cites·6 claims
- 0577US11753385B2Method for producing kakeromycin and derivatives thereofOP BIO FACTORY CO LTD·Filed 2021·Granted Sep 12, 2023·0 cites·13 claims
- 0674US4767768ANitro aliphatic compounds, process for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1983·Granted Aug 30, 1988·10 cites·14 claims
- 0769US9896457B2Microbial product having antifungal activityOP BIO FACTORY CO LTD·Filed 2014·Granted Feb 20, 2018·3 cites·7 claims
- 0868US11155526B2Method for producing kakeromycin and derivatives thereofOP BIO FACTORY CO LTD·Filed 2018·Granted Oct 26, 2021·0 cites·9 claims
- 0966US5192678ACephalosporin c acylaseFUJISAWA PHARMACEUTICAL CO·Filed 1991·Granted Mar 9, 1993·24 cites·2 claims
- 1058US5320948ACephalosporin C acylaseFUJISAWA PHARMACEUTICAL CO·Filed 1992·Granted Jun 14, 1994·16 cites·7 claims
- 1157US4578271ABiologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositionsFUJISAWA PHARMACEUTICAL CO·Filed 1983·Granted Mar 25, 1986·7 cites·8 claims
- 1256US4863926ANitro aliphatic compounds, process for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1987·Granted Sep 5, 1989·5 cites·12 claims
- 1351US5677141AProcess for producing 7-aminocephem compound or salts thereofFUJISAWA PHARMACEUTICAL CO·Filed 1994·Granted Oct 14, 1997·12 cites·11 claims
- 1449US4778804ANitro aliphatic compounds, process for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1985·Granted Oct 18, 1988·3 cites·12 claims
- 1548US5310659AGL-7ACA acylaseFUJISAWA PHARMACEUTICAL CO·Filed 1991·Granted May 10, 1994·4 cites·4 claims
- 1647US4645765ATetracyclo compounds and a pharmaceutical composition containing the sameFUJISAWA PHARMACEUTICAL CO·Filed 1985·Granted Feb 24, 1987·4 cites·15 claims
- 1739US4782088ANitro aliphatic compounds and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1986·Granted Nov 1, 1988·1 cites·3 claims
- 1838US10980813B2Antifungal compositionSEED RES INSTITUTE CO LTD·Filed 2018·Granted Apr 20, 2021·0 cites·20 claims
- 1938US2004053323A1Method of screening inducible nitric oxide synthase activation inhibitorFiled 2001·Application pending·0 cites
- 2034US4950605AFR-900493 substance, a process for its production and a pharmaceutical composition containing the sameFUJISAWA PHARMACEUTICAL CO·Filed 1989·Granted Aug 21, 1990·1 cites·6 claims
- 2133US9988396B2Oxaziridine compound and production method thereofSEED RES INSTITUTE CO LTD·Filed 2017·Granted Jun 5, 2018·0 cites·10 claims
- 2230US4743555ABiologically pure culture of Streptomyces sandaensis No. 6897FUJISAWA PHARMACEUTICAL CO·Filed 1986·Granted May 10, 1988·1 cites·2 claims
- 2329US4861774AMethod of treating tumors using tetracyclo compoundsFUJISAWA PHARMACEUTICAL CO·Filed 1986·Granted Aug 29, 1989·0 cites·5 claims
- 2429US4661352AWS 7739 substances, their preparation and pharmaceutical composition containing the sameFUJISAWA PHARMACEUTICAL CO·Filed 1984·Granted Apr 28, 1987·0 cites·4 claims
- 2526US5312750AGL-7ACA acylaseFUJISAWA PHARMACEUTICAL CO·Filed 1993·Granted May 17, 1994·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Morita Iwami files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →